The Nordic countries have a growing biotechnology sector focused on developing treatments for neurodegenerative diseases. Sweden in particular has a strong tradition in neuroscience research, with companies developing innovative therapies for Alzheimer's, Parkinson's, and other neurodegenerative conditions.
Swedish Companies
BioArctic AB
BioArctic AB is a Swedish biopharma company focused on developing novel treatments for Alzheimer's disease.
Headquarters: Stockholm, Sweden
Focus: Alzheimer's disease, Parkinson's disease
Key programs:
BAN2401 (lecanemab) - [Amyloid-beta](/proteins/amyloid-beta) antibody (partnered with Eisai)
ABBV-0805 - [Tau](/proteins/tau) antibody for PSP (formerly Novanano)
[Alpha-synuclein](/proteins/alpha-synuclein) antibodies for PD
Status: Clinical trials
Araize AB
Araize is a Swedish biotech developing RNA-based therapies for neurodegenerative diseases.
Headquarters: Stockholm
Focus: Alzheimer's disease
Approach: RNA interference
Status: Preclinical
2A Pharma AB
2A Pharma is a Swedish company focused on developing drugs for neurological disorders.
Headquarters: Lund, Sweden
Focus: Neurodegeneration
Approach: Novel small molecules
Status: Research
Lipigon Pharmaceuticals
Lipigon is a Swedish biotech developing therapies for lipid-related diseases including neurodegeneration.
Headquarters: UmeƄ, Sweden
Focus: Lipid metabolism in neurodegeneration
Approach: RNA-based therapeutics
Status: Preclinical
Obsidian Therapeutics (Swedish operations)
Obsidian has operations in Sweden focused on tumor microenvironment and neuroimmunology.
Headquarters: US (with Stockholm operations)
Focus: Neuroimmunology
Approach: Immunomodulation
Norwegian Companies
Neurodegeneration Research Norway
Norwegian research groups focused on neurodegenerative disease research:
Oslo University Hospital: Parkinson's research
University of Bergen: Tau research
NTNU: Neuroprotection studies
Spinco Biotech
Spinco is a Norwegian biotech developing treatments for neurological disorders.
Headquarters: Oslo, Norway
Focus: Parkinson's disease
Approach: Novel small molecules
Status: Research
NNeuro AS
NNeuro is a Norwegian company focused on nerve regeneration.
Headquarters: Trondheim, Norway
Focus: Neuroprotection
Approach: Neurotrophic factors
Status: Preclinical
Danish Companies
Lundbeck
H. Lundbeck is a major Danish pharmaceutical company with significant neuroscience R&D.